FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when
Read MorePackages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreA pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez | Tribune News Service | Getty
Read MoreSource/Disclosures Published by: Disclosures: Lynch and Shaman report being supported by grants from the NIH. Shaman and Columbia University are
Read MoreSource/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when
Read MoreKFF Health New correspondent Jazmin Orozco Rodriguez discussed the shortage of foster care homes in rural Nevada on The Nevada
Read MoreIn this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San
Read MoreSource/Disclosures Published by: Source: Wichmann G, et al. Cancers (Basel).2023;doi:10.3390/cancers15133356. Disclosures: Wichmann reports no relevant financial disclosures. Please see the
Read MoreFollowing a 1976 swine flu vaccination campaign in New Jersey, increased reports of Guillain-Barre syndrome (GBS) raised concern throughout the
Read More